<DOC>
	<DOCNO>NCT00691379</DOCNO>
	<brief_summary>This study evaluate efficacy weekly paclitaxel-carboplatin combination plus bevacizumab first line treatment patient metastatic triple negative breast cancer . Furthermore , efficacy combination therapy correlate presence circulate tumor cell ( CTCs ) population</brief_summary>
	<brief_title>Weekly Paclitaxel/Carboplatin/Bevacizumab First Line Therapy Triple Negative Breast Cancer</brief_title>
	<detailed_description>Breast cancer absent low expression hormone receptor HER2 ( triple negative ) respond hormonal biological therapy trastuzumab . However , triple negative breast cancer highly sensitive chemotherapy . The combination paclitaxel carboplatin administer weekly basis active well tolerate . Recently , initial therapy metastatic breast cancer paclitaxel plus bevacizumab demonstrate prolonged progression-free survival , compare paclitaxel alone</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically cytologically confirm metastatic breast adenocarcinoma No HER2 overexpression gene amplification Absent low ER PR expression No previous therapy metastatic breast cancer allow Age 1875 year Measurable disease define presence least one measurable lesion ( except bone metastasis , ascites pleural effusion ) Performance status ( WHO ) 02 Adequate liver ( serum bilirubin &lt; 1.5 time upper normal limit , AST ALT &lt; 2.5 time upper normal limit absence demonstrable liver metastasis , &lt; 5 time upper normal limit presence liver metastasis ) adequate renal function ( serum creatinine &lt; 1.5 time upper normal limit ) bone marrow ( neutrophils ≥ 1.5x 109 /L , platelet ≥ 100x 109 /L ) No radiation measurable disease ( except brain metastasis ) No progressive brain metastasis accord clinical radiological criterion No brain metastases without prior radiation therapy Written inform consent Active infection History significant cardiac disease ( unstable angina , congestive heart failure , myocardial infarction within previous 6 month , ventricular arrhythmia ) History stroke Anticoagulation therapy ( except low dose aspirin &lt; 325mg ) Other invasive malignancy except nonmelanoma skin cancer Psychiatric illness social situation would preclude study compliance Pregnant lactating woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Triple negative</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Anti-angiogenesis therapy</keyword>
</DOC>